- Home
- RDN vs TERN Comparison
RDN vs TERN Comparison
Compare RDN & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RDN | TERN |
|---|---|---|
| Founded | 1977 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.8B |
| IPO Year | 2008 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RDN | TERN |
|---|---|---|
| Price | $34.19 | $52.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 11 |
| Target Price | $40.00 | ★ $46.72 |
| AVG Volume (30 Days) | 1.1M | ★ 10.0M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.95% | N/A |
| EPS Growth | 5.61 | ★ 8.04 |
| EPS | ★ 4.14 | N/A |
| Revenue | ★ $1,197,084,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.66 | N/A |
| P/E Ratio | $8.35 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.32 | $2.15 |
| 52 Week High | $38.84 | $53.19 |
Technical Indicators
Market Signals| Indicator | RDN | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 57.26 | 73.54 |
| Support Level | $32.00 | $38.99 |
| Resistance Level | $34.81 | $53.19 |
| Average True Range (ATR) | 0.70 | 0.56 |
| MACD | 0.20 | -0.28 |
| Stochastic Oscillator | 67.33 | 89.86 |
Price Performance
Historical ComparisonAbout RDN Radian Group Inc.
Radian Group Inc is engaged in mortgage and real estate services. It provides both credit-related mortgage insurance coverage and other products and services across the residential real estate and mortgage finance industries. It has one business segment Mortgage Insurance. The Mortgage Insurance segment aggregates, manages, and distributes U.S. mortgage credit risk for the benefit of mortgage lending institutions and mortgage credit investors, through private mortgage insurance on residential first-lien mortgage loans, and also offers other credit risk management solutions, including contract underwriting, to customers. It also provides other mortgage and real estate products and services through Mortgage Conduit, Title, Real Estate Services, and Real Estate Technology businesses.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.